LS Investment Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
LCOV
LCP
LS Investment Advisors's HAE Position: Q2 2021 in Review
LS Investment Advisors sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 2,127 shares — an estimated $236K sold.
LS Investment Advisors first reported a position in HAE in Q2 2015 and held it in 24 quarters. The position peaked at $395K in Q3 2019. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.
- LS Investment Advisors reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
- LS Investment Advisors sold 2,127 Haemonetics shares in Q2 2021, an estimated $236K.
- LS Investment Advisors first reported a position in Haemonetics in Q2 2015 and held it in 24 quarters.
- LS Investment Advisors's Haemonetics position peaked at $395K in Q3 2019.
- 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.
Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.